|
|||||
|
|
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence |
|
| Authors: | Johan Dalén Axel Svedbom Christopher M. Black Ramon Lyu Qian Ding Shiva Sajjan Vasilisa Sazonov Sumesh Kachroo |
| Affiliation: | 1.Mapi Group,Stockholm,Sweden;2.Department of Medicine,Karolinska Institutet,Solna,Sweden;3.Merck & Co., Inc.,Rahway,USA;4.MSD Inovativna Zdravilla,Ljubljana,Slovenia |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |